Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC

Clinical trial NCT04375150 · COMPLETED

Trial details

NCT number: NCT04375150
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma (RCC)

Start date: 2019-12-02
Primary completion: 2022-10-28
Enrollment: 355

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.